You just read:

Shrink Nanotechnologies Announces That Critical Cell Align Tissue Engineering Platform Patent as Well as IP on a Novel Immunoassay Substrate Material Has Been Filed With the USPTO

News provided by

Shrink Nanotechnologies, Inc.

Apr 15, 2011, 04:05 ET